Cytokines and tear function in ocular surface disease

Advances in Experimental Medicine and Biology

Volumn 438, Issue , 1998, Pages 461-469

  Barton, Keith ^a,b   Nava, Alexandra ^a   Monroy, Dagoberte C ^a   Pflugfelder, Stephen C ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR;

ADULT; AGED; CHRONIC INFLAMMATION; CONFERENCE PAPER; DISEASE ASSOCIATION; DRY EYE; FEMALE; HUMAN; LACRIMATION; MAJOR CLINICAL STUDY; MALE; MEDIATOR RELEASE; PRIORITY JOURNAL; PROTEIN DETERMINATION; ROSACEA; SCHIRMER TEST; SLIT LAMP;

ROSACEA;

EID: 0031775462     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5359-5_64     Document Type: Conference Paper

References (43)

1. Yoshino K, Monroy DC, Pflugfelder SC. Cholinergic stimulation of lactoferrin and EGF secretion by the human lacrimal gland. Cornea. 1996;15:617-621.
2. Ohashi Y, Motokura M, Kinoshita Y, et al. Presence of epidermal growth factor in human tears. Invest Ophthalmol Vis Sci. 1989;30:1879-1882.
3. van Selten G, Viinikka L, Tervo T, Pesonen K, Tarkkanen A, Perheentupa J. Epidermal growth factor is a constant component of normal tears. Graefes Arch Clin Exp Ophthalmol. 1989;227:184-187.
4. van Setten G. Epidermal growth factor in human tear fluid: Increased release but decreased concentrations during reflex tearing. Curr Eye Res. 1990;9:79-83.
5. Watanabe K, Nakagawa S, Nishida T. Stimulatory effects of fibronectin and EGF on migration of comeal epithelial cells. Invest Ophthalmol Vis Sci. 1987;28:205-211.
6. Mishima H, Nakamura M, Murakami J, Nishida T, Otori T. Transforming growth factor-beta modulates effects of epidermal growth factor on comeal epithelial cells. Curr Eye Res. 1992;11:691-696.
7. Grant MB, Khaw PT, Schultz GS, Adams JL, Shimizu RW. Effects of epidermal growth factor, fibroblast growth factor, and transforming growth factor-beta on corneal cell chemotaxis. Invest Ophthalmol Vis Sci. 1992;33:3292-3301.
8. Boisjoly HM, Laplante C, Bernatchez SF, et al. Effects of EGF, IL-1 and their combination on in vitro corneal epithelial wound closure and cell chemotaxis. Exp Eye Res. 1993;57:293-300.
9. Nishida T, Nakamura M, Murakami J, Mishima H, Otori T. Epidermal growth factor stimulates corneal epithelial cell attachment to fibronectin through a fibronectin receptor system. Invest Ophthalmol Vis Sci. 1992;33:2464-2469.
10. Wilson SE, He YG, Weng J, Zieske JD, Jester JV, Schultz GS. Effect of epidermal growth factor, hepatocyte growth factor, and keratinocyte growth factor, on proliferation, motility and differentiation of human corneal epithelial cells. Exp Eye Res. 1994;59:665-678.
11. Nava A, Barton K, Monroy DC, Pflugfelder SC. The effects of age, gender and fluid dynamics on the concentration of tear film epidermal growth factor. Cornea. 1997;16:430-438.
12. Barton K, Nava A, Monroy DC, Pflugfelder SC. Inflammatory cytokines in the tears of patients with ocular rosacea. Ophthalmology. 1997;104:In press.
13. Jenkins MS, Brown SI, Lempert SL, Weinberg RJ. Ocular rosacea. Am J Ophthalmol. 1979;88:619-622.
14. Pflugfelder SC, Tseng SCG, Yoshino K, Monroy DC, Felix C, Reis BL. Correlation of goblet cell density and mucosal epithelial membrane mucin expression with rose bengal staining in patients with ocular irriation. Ophthalmology. 1997;104:222-235.
15. Shimazaki J, Sakata M, Tsubota K. Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol. 1995;113:1266-1270.
16. McCulley JP, Sciallis GF. Meibomian keratoconjunctivitis. Am J Ophthalmol. 1977;84:788-792.
17. Mathers WD. Ocular evaporation and meibomian gland dysfunction in dry eye. Ophthalmology. 1993;100:347-351.
18. Lemp MA. Report of the National Eye Institute/industry workshop on clinical trials in dry eyes. CLAO J. 1995;21:221-232.
19. Xu K, Yagi Y, Toda I, Tsubota K. Tear function index: A new measure of dry eye. Arch Ophthalmol. 1995;113:84-88.
20. Gupta A, Monroy DC, Zhonghua J, Yoshino K, Huang A, Pflugfelder SC. Transforming growth factor beta-1 and beta-2 in human tear fluid. Curr Eye Res. 1996;15:605-614.
21. Gupta C, Singh M. Stimulation of epidermal growth factor gene expression during the fetal mouse reproductive tract differentiation: Role of androgen and its receptor. Endocrinology. I996;137:705-711.
22. Motta M, Dondi D, Moretti RM, et al. Role of growth factors, steroid and peptide hormones in the regulation of human prostatic tumor growth. [Review]. J Steroid Biochem Mol Biol. 1996;56:107-111.
23. Yang Y, Chisholm GD, Habib FK. Epidermal growth factor and transforming growth factor alpha concentrations in BPH and cancer of the prostate: Their relationships with tissue androgen levels. Br J Cancer. 1993;67:152-155.
24. Sullivan DA, Bloch KJ, Allansmith MR. Hormonal influence on the secretory immune system of the eye: Androgen regulation of secretory component levels in rat tears. J Immunol. 1984;132:1130-1135.
25. Sullivan DA, Allansmith MR. Hormonal influence on the secretory immune system of the eye: Endocrine interactions in the control of IgA and secretory component levels in tears of rats. Immunology. 1987;60:337-343.
26. Gao J, Lambert RW, Wickham LA, Banting G, Sullivan DA. Androgen control of secretory component mRNA levels in the rat lacrimal gland. J Steroid Biochem Mol Biol. 1995;52:239-249.
27. Cornell-Bell AH, Sullivan DA, Allansmith MR. Gender-related differences in the morphology of the lacrimal gland. Invest Ophthalmol Vis Sci. 1985;26:1170-1175.
28. Sato EH, Sullivan DA. Comparative influence of steroid hormones and immunosuppressive agents on autoimmune expression in lacrimal glands of a female mouse model of Sjögren's syndrome. Invest Ophthalmol Vis Sci. 1994;35:2632-2642.
29. Jordan A, Baum J. Basic tear flow: Does it exist? Ophthalmology. 1980;87:920-930.
30. McGill JI, Liakos G, Seal DV. Normal tear protein profiles and age-related changes. Br J Ophthalmol. 1984;68:316-320.
31. Mathers WD, Lane JA, Zimmerman MB. Tear film changes associated with normal aging. Cornea. 1996;15:229-234.
32. Xu K, Tsubota K. Correlation of tear clearance rate and fluorophotometric assessment of tear turnover. Br J Ophthalmol. 1995;79:1042-1045.
33. Pflugfelder SC, Tseng SCG, Pepose JS, Fletcher MA, Klimas NG, Feuer W. Epstein-Barr viral infection and immunologic dysfunction in patients with aqueous tear deficiency. Ophthalmology. 1990;97:313-323.
34. Mishima S, Gasset A, Klyce SD, Jr., Baum JL. Determination of tear volume and tear flow. Invest Ophthalmol. Vis Sci 1966;5:264-276.
35. Hogquist KA, Nett MA, Unanue ER, Chaplin DD. Interleukin-1 is processed and released during apoptosis. Proc Natl Acad Sci USA. 1991;88:8485-8489.
36. Dinarello CA, Wolff SM. The role of interleukin-l in disease. N Engl J Med. 1993;328:106-113.
37. Dinarello CA. Interleukin-1 and its biologically related cytokines. Adv immunol. 1989;44:153-205.
38. Wilson SE, He YG, Lloyd SA. EGF, EOF receptor, basic FGF, TGF beta-1, and IL-1 alpha mRNA in human corneal epithelial cells and stromal fibroblasts. Invest Ophthalmol Vis Sci. 1992;33:1756-1765.
39. Wilson SE, Schultz GS, Chegini N, Weng J, He Y. Epidermal growth factor, transforming growth factor alpha, transforming growth factor beta, acidic fibroblast growth factor, basic fibroblast growth factor, and interleukin-1 proteins in the cornea. Exp Eye Res. 1994;59:63-70.
40. Schmidt JA, Tocci MJ. Interleukin-1. In: Sporn MD, Roberts AB, eds. Peptide Growth Factors and Their Receptors. New York: Springer-Verlag; 1991:473-521.
41. Girard MT, Matsubara M, Fini ML. Transforming growth factor beta and interleukin-1 modulate metalloproteinase expression by corneal stromal cells. Invest Ophthalmol Vis Sci. 1991;32:2441-2454.
42. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood. 1991;77:1627-1652.
43. Hykin PG, Bron AJ. Age-related morphological changes in lid margin and meibomian gland anatomy. Cornea. 1992;11:334-342.